MC-GGFG-AM- (10NH2-11F-Camptothecin)
MC-GGFG-AM- (10NH2-11F-Camptothecin) is an antibody drug conjugates (ADC) . MC-GGFG-AM- (10NH2-11F-Camptothecin) binds to the anti-TROp-2 antibody sacituzumab via a hydrolysable pH-sensitive linker and has anti-tumor activity. MC-GGFG-AM- (10NH2-11F-Camptothecin) can be used for cancer research[1].
Product Specifications
CAS Number
2987938-97-4
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mc-ggfg-am-10nh2-11f-camptothecin.html
Solubility
10 mM in DMSO
Smiles
O=C1N2C(C(C(C2)=CC3=C4)=NC3=CC(F)=C4NC(CNC([C@@H](NC(CNC(CNC(CCCCCN5C(C=CC5=O)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=O)=CC7=C1COC([C@]7(O)CC)=O
Molecular Formula
C45H45FN8O11
Molecular Weight
892.88
References & Citations
[1]Petersen, M. E, et al. Camptothecin analogues, conjugates and methods of use. WO2022246576 A1.2022-01-12.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF488A conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF594 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
